Document is current
Any future updates will be listed below
-
Authors
Farisogullari, Bayram
Cuceoglu, Muserref Kasap
Oral, Hakan
Yardimci, Gozde Kubra
Bilginer, Yelda
Ozen, Seza
Karadag, Omer https://orcid.org/0000-0002-3443-3117
- License Information
-
More Information
Article History
Received: 30 August 2021
Accepted: 1 March 2022
First Online: 26 March 2022
Declarations
:
: Professor Karadag: Received consultancy fees and/or speaker fees from Abbvie, Pfizer, Roche, Novartis, outside the submitted work. Lecturer for Abbvie, Abdi Ibrahim, Amgen, Celltrion, Farmanova, Janssen, Lilly, Pfizer, Roche, UCB, outside the submitted work. Other authors have no conflict of interest.
: The study was approved by the institutional ethics committee.
: Informed consent was obtained from all of the patients.
